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The killer lymphocyte protease granzyme A (GzmA)
triggers caspase-independent target cell death with
morphological features of apoptosis. We previously
showed that GzmA acts directly on mitochondria to
generate reactive oxygen species (ROS) and disrupt
the transmembrane potential (DJm) but does not
permeabilize the mitochondrial outer membrane. Mi-
tochondrial damage is critical to GzmA-induced cell
death since cells treatedwith superoxide scavengers
are resistant to GzmA. Here we find that GzmA ac-
cesses the mitochondrial matrix to cleave the com-
plex I protein NDUFS3, an iron-sulfur subunit of the
NADH:ubiquinone oxidoreductase complex I, after
Lys56 to interfere with NADH oxidation and generate
superoxide anions. Target cells expressing a cleav-
age site mutant of NDUFS3 are resistant to GzmA-
mediated cell death but remain sensitive to GzmB.
INTRODUCTION
Mitochondrial disruption is a hallmark of caspase-dependent ap-
optosis (Kroemer et al., 2007). The mitochondrial outer mem-
brane (MOM) is disrupted, causing the release of proapoptotic
molecules such as cytochrome c, AIF, HtrA2/Omi, Smac/Diablo,
and endoG. Released cytochrome c activates caspase-9. At the
same time, damaged mitochondria generate excessive reactive
oxygen species (ROS) and the mitochondrial transmembrane
potential (DJm) dissipates. Most mitochondrial apoptosis re-
search has emphasized the importance of MOM permeabiliza-
tion (MOMP), leaving it unclear whether ROS generation is
incidental or essential to apoptosis.
Killer lymphocytes (cytotoxic T lymphocytes [CTLs] and NK
cells) trigger both caspase-dependent and -independent apo-
ptosis by releasing the contents of specialized secretory lyso-
somes, called cytotoxic granules, into the immune synapse
formed with a cell targeted for destruction (Chowdhury and Lie-
berman, 2008). The cell death inducers are the granzyme (Gzm)
serine proteases, of which there are five isoforms in humans and
ten in mice. Gzms are delivered into the target cell cytosol by
perforin (PFN). Granzyme A (GzmA) and B (GzmB) are the mostabundant Gzms. GzmA induces cell deathmorphologically indis-
tinguishable from apoptosis, but caspase inhibition or bcl-2 fam-
ily expression does not affect it (Beresford et al., 1999; Chowd-
hury and Lieberman, 2008; Shresta et al., 1999). GzmA causes
single-stranded DNA damage rather than oligonucleosomal
double-stranded DNA breaks by activating two nucleases work-
ing sequentially, an endonuclease (NM23-H1) and an exonucle-
ase (TREX1) (Chowdhury et al., 2006; Fan et al., 2003). NM23-H1
and TREX1 are in the ER-associated SET complex, together with
an inhibitor (SET). Upon GzmA exposure, the SET complex
translocates to the nucleus, where GzmA cleaves SET, liberating
NM23-H1 to initiate DNA damage (Fan et al., 2003). GzmB
cleaves and activates effector caspases and many critical cas-
pase substrates. Superoxide scavengers block cell death by
CTLs expressing both GzmA and GzmB, suggesting that gener-
ating ROS may be critical for both caspase-dependent and -in-
dependent programmed cell death (Aronis et al., 2003; Hildeman
et al., 1999; Malassagne et al., 2001; Martinvalet et al., 2005;
Sandstrom et al., 1994).
Within minutes of being introduced into cells, GzmA causes
increased ROS and DJm dissipation. GzmA perturbation of iso-
lated mitochondria is insensitive to bcl-2, caspase inhibition, or
cytosolic factors (Martinvalet et al., 2005; Pardo et al., 2004).
Bid is not cleaved and apoptogenic factors are not released
(Martinvalet et al., 2005). Moreover, mitochondrial damage by
GzmA does not require bak or bax, the bcl-2 family members in-
volved in bid-mediated mitochondrial damage (Zhu et al., 2006).
Therefore GzmA activates a caspase-independent mitochon-
drial cell death pathway without MOMP. The goal of this study
is to define its molecular basis.
GzmA is a highly selective tryptase. Only a handful of intracel-
lular substrates, including SET, Ape1, and HMGB2 in the SET
complex, as well as lamins, histones, and Ku70, have been iden-
tified as physiologically relevant (Chowdhury and Lieberman,
2008). GzmA binds to its substrates by an extended exosite,
which may explain both its substrate specificity and the fact
that its substrate cleavage sites do not share a common peptide
sequence (Bell et al., 2003; Hink-Schauer et al., 2003). Since
GzmA acts directly on mitochondria, mitochondrial damage by
GzmA is likely activated by GzmA proteolysis of mitochondrial
substrate(s). To begin to define the GzmA mitochondrial path-
way, we used two-dimensional (2D) differential gel electrophore-
sis to identify potential GzmA substrates in isolated intact mouse
liver mitochondria. This approach was first adapted byCell 133, 681–692, May 16, 2008 ª2008 Elsevier Inc. 681
Bredemeyer et al. (2004) to identify Gzm substrates. NDUFS3 in
complex I, one of two complexes in the electron transport chain
(ETC) capable of generating ROS (Camello-Almaraz et al., 2006;
Grivennikova and Vinogradov, 2006), is a GzmA target. NDUFS3
cleavage disrupts complex I function to initiate superoxide-
dependent, but MOMP-independent, cell death.
RESULTS
GzmA Induces ROS by Directly Targeting Mitochondria
A sublytic dose of PFN, which causes death in 10% of cells on
its own, was used to deliver recombinant human GzmA into hu-
man K562 cells. PFN loading of GzmA caused dose-dependent
increased ROS, measured by conversion of superoxide anion-
reactive hydroethidine (HE) to ethidium (Figure S1A available
Figure 1. GzmA Targets Mitochondria to
Produce ROS and Alters Mitochondrial
Morphology
(A) HeLa cells were loaded with MitoTracker Deep
Red and MitoSOX, a mitochondrial superoxide
dye, and then treated with PFN alone (top) or
PFN plus recombinant human GzmA (bottom)
and analyzed by live-fluorescence microscopy.
Superoxide anion is detected within 2 min in
GzmA-exposed mitochondria, and mitochondria
lose their characteristic elongated shape (insets).
(B) Electronmicrographs of HeLa cells treatedwith
GzmA alone (left) or PFN + GzmA (right). Higher
magnification images are below. Mitochondria
round up and lose their cristae when GzmA is
delivered by PFN. Plasma membrane (P), nucleus
(N), and mitochondrion (m). Results are represen-
tative of at least three experiments.
online). Cells treated with either GzmA or
PFN alone showed little change in ROS.
GzmA- and PFN-treated cells also
stained with the vital ROS indicator 20,
70-dichlorodihydrofluorescein diacetate
(H2DCFDA), which reacts with cytosolic
ROS (Figure S1B). Pretreatment with
pan-caspase inhibitors at caspase-inhib-
iting concentrations had little effect on
ROS production (Figure S1C). Therefore,
GzmA induces caspase-independent
increased ROS. GzmA acts directly on
mitochondria since GzmA treatment of
isolated mitochondria rapidly increased
ROS production, which was unaltered
by adding S100 cytosol (Figure S1D).
To determine whether mitochondria
are the source of ROS in intact cells
treated with GzmA and PFN, we imaged
live HeLa cells, prelabeled with Mito-
tracker Deep Red and MitoSOX Red, a
vital mitochondrial dye that fluoresces se-
lectively in response to superoxide anion
(Mukhopadhyay et al., 2007). PFN or
GzmA alone did not increase MitoSOX staining (Figure 1A and
data not shown). Within a fewminutes of adding GzmAwith PFN,
MitoSOX fluorescence increased and mitochondria appeared to
round up (Figure 1A). This morphological change was confirmed
by electron microscopy (Figure 1B). Within 10 min of adding
GzmA and PFN, mitochondria swelled, rounded, and lost many
of their cristae.
Althoughmitochondria are the primary site of superoxide anion
generation, other organelles, such as the ER, may be involved in
free radical-induced cell death (Haynes et al., 2004). Live-fluores-
cence microscopy was performed on cells colabeled with Mito-
Sox and H2DCFDA, which reacts with cytosolic ROS. Cells
treated with PFN and GzmA showed only MitoSOX, but not
H2DCFDA, staining (not shown). Since treated cells stained with
H2DCFDA in the absence of MitoSox costaining (Figure S1B),682 Cell 133, 681–692, May 16, 2008 ª2008 Elsevier Inc.
the lack of cytosolic ROS is likely due toMitoSOX scavenging su-
peroxide anions before they are released into the cytosol. There-
fore mitochondria are the major source of GzmA-induced ROS.
Ndufs3 in Mitochondrial Complex I Is a Putative
GzmA Substrate
A proteomics approach was used to identify potential mitochon-
drial targets. Purified mouse liver mitochondria were mock
treated or treated with 2.5 mM recombinant human GzmA for
10 min and then lysed in the presence of protease inhibitors. Mi-
tochondrial proteins were resolved by 2D gel electrophoresis
(Figures 2A and 2B) and analyzed using Protetix 2D software
(Nonlinear Dynamics). Approximately 307 protein spots were
detected per gel. The mitochondria project 2 (MitoP2) has anno-
tated 612 mouse mitochondrial proteins and estimated that it
covers approximately half of the mitochondrial proteome (Pro-
kisch et al., 2006). A systematic mass spectrometry survey of
mouse mitochondrial proteins isolated from various tissues esti-
mated the size of the mitochondrial proteome at 591 (Mootha
et al., 2003). Therefore, our 2D gel analysis displays a large
proportion of the predicted mouse mitochondrial proteome.
Only a few spots disappeared in theGzmA-treated gels. These
spots were picked from the control gel, digested with trypsin,
and characterized by mass spectrometry. Two candidate mito-
chondrial substrates, Atp5H and Ndufs3, were selected for fur-
Figure 2. GzmACleaves Ndufs3, the 30 kDa Subunit of
Mitochondrial Complex I
(A) Proteomic analysis. Freshly purified mouse liver mitochon-
dria were treated with buffer or human GzmA for 10 min and
resolved by 2D gel electrophoresis and silver staining. Most
spots were unchanged. Spots 1 and 2 on the control gel, cor-
responding to missing proteins in the GzmA-treated sample,
were excised and characterized by mass spectrometry.
(B) Magnification of the region corresponding to spots 1 and 2.
Excised spots are indicated with arrows. Mass spectroscopy
identified spot 1 as Ndufs3 and spot 2 as Atp5h. Spot 1 par-
tially overlaps with another unchanged spot of higher apparent
molecular mass and more acidic isoelectric point.
(C and D) Human K562 cells treated with human GzmA and
PFN confirmed that GzmA specifically cleaves NDUFS3, but
not ATP5H, in a dose- (C) and time-dependent (D) manner.
SET is a previously described GzmA target. NDUFS3 was
cleaved by GzmA but not GzmB. However, ATP5H was not
a substrate for either Gzm. NDUFA9 is another complex I pro-
tein and Hsp60 is a mitochondrial loading control. Results are
representative of at least four experiments.
ther investigation. Three peptides covering 14%
of the amino acid sequence of Ndufs3 and nine
peptides covering 60% of Atp5h were identified.
Atp5h is the 15 kDa d subunit in the connecting stalk
between the ATP synthase F1 catalytic domain and
the F0 integral membrane portion of the ATP
synthase complex in the inner membrane (Papa
et al., 2000). Ndufs3 is a 30 kDa subunit of the
NADH:ubiquinone oxidoreductase ETC complex I,
which catalyzes the first step of electron transfer
from NADH to a noncovalently bound flavin mono-
nucleotide and then, via a series of iron-sulfur clusters, to the ter-
minal acceptor ubiquinone (Hirst et al., 2003). Ndufs3 is one of
the iron-sulfur cluster proteins. Both Atp5h and Ndufs3 are
good candidates for ROS generation since they are directly in-
volved in electron transfer and coupling. Since either complex I
or complex III can generate superoxide anion, Ndufs3 in complex
I is especially attractive (Grivennikova and Vinogradov, 2006).
To determine whether Ndufs3 and Atp5h are physiologically
relevant targets, we evaluated their cleavage in human K562
cells treated with PFN and recombinant human GzmA. Although
the proteomic analysis was performed using mouse mitochon-
dria, we chose to validate our results in human cells since pro-
teins targeted in both species would be more likely to be signif-
icant. NDUFS3 was cleaved in cells treated with GzmA and PFN
in a dose-dependent manner that paralleled cleavage of SET,
a well-characterized GzmA substrate (Figure 2C) (Chowdhury
and Lieberman, 2008). No immunoreactive NDUFS3 cleavage
product was detected, most likely because the cleavage frag-
ments are labile within cells. This is a feature of most other
GzmA substrates (only SET and Ku70 fragments are detected
in vivo) (Zhu et al., 2006). No difference in NDUFS3 cleavage
was observed in the presence of o-phenanthroline, an inhibitor
of AAA ATP-dependent proteases (data not shown), eliminating
a role for these mitochondrial proteases in NDUFS3 cleavage.
Processing of NDUFS3 was specific since NDUFA9, anotherCell 133, 681–692, May 16, 2008 ª2008 Elsevier Inc. 683
complex I subunit, was not cleaved. Although Atp5h was a puta-
tive GzmA target, ATP5H was unaltered in K562 cells treated
with both PFN andGzmA, suggesting that it was not a physiolog-
ically relevant substrate in human cells (Figures 2C and 2D).
Since no antibody to mouse Atp5h is available, we were unable
to test Atp5h cleavage in mouse cells. However, since human
and mouse Atp5h are highly homologous (81% identity) and
GzmA substrates are recognized by an extended interaction do-
main, mouse Atp5h is not a likely relevant substrate. NDUFS3
cleavage in K562 cells was evident within 30 min of treating cells
with GzmA and PFN (Figure 2D). In both experiments the highly
homologous GzmB (recombinant mouse protein used through-
out) had no effect on NDUFS3. Blotting for Hsp60 verified com-
parable mitochondrial protein loading across samples. The
specificity and cross-species importance of NDUFS3 as a sub-
strate were also tested by treating mouse complex I, purified
by immunocapture as described (Keeney et al., 2006), with cyto-
toxic granules isolated from a rat NK cell line (Figure S2). Both
recombinant human GzmA and rat NK cell granules, but not re-
combinant mouse GzmB, cleaved mouse Ndufs3, but not
Ndufb6, another complex I protein. Therefore NDUFS3, but not
ATP5H, is a good candidate for a physiologically relevant
GzmA substrate in both human and rodent cells.
GzmA Directly Cleaves NDUFS3 after Lys56
To determine whether NDUFS3 is a direct substrate, recombi-
nant human NDUFS3 (rhNDUFS3), expressed with a C-terminal
His6 tag, was incubated with human recombinant GzmA, enzy-
matically inactive GzmA produced by mutating the active site
Ser176 to Ala (S-AGzmA), or mouse GzmB. GzmA efficiently
cleaved rhNDUFS3 at GzmA concentrations as low as 250 nM
(Figure 3A). A 23.6 kDaC-terminal fragment was readily detected
Figure 3. GzmA Directly Cleaves Human
NDUFS3 and Mouse Ndufs3
(A) rhNDUFS3 was specifically and directly cleaved
byhumanGzmA,butnotmouseGzmB,toa26.3kDa
C-terminal fragment detected by immunoblot with
His6 antibody. Mass spectroscopy of this fragment
identified Lys56 as the NDUFS3 cleavage site.
(B–D) To confirm the cleavage site and its relevance
in intact cells, WT or K56A-NDUFS3 or control vec-
tor were expressed with a HA tag in K562 cells (B,
immunoblot with HA antibody) and verified to be in-
corporated into complex I by HA antibody immuno-
precipitation (C). NDUFA9, MTND6, and NDUFB6
are other complex I proteins (D). When transduced
K562 cells were treated with GzmA and PFN for
1 hr, WT NDUFS3 was degraded, verifying Lys56
as the in vivo GzmA cleavage site. K56A-NDUFS3
is cleaved somewhat by GzmA but is more resistant
than WT NDUFS3. Cleavage of the GzmA target
SET serves as a positive control and Hsp60 is a
negative loading control.
(E) SimilarlyK56A-NDUFS3overexpressed inmouse
EL4 cells (immunoblot, left) was relatively resistant to
cleavage byGzmA. EL4 cells transducedwithWT or
K56A-NDUFS3 were lysed and treated for 20 min
with the indicated GzmA concentration (right) or
treated for indicated times with 250 nM GzmA (bot-
tom). In (B)–(E) transduced NDUFS3 was detected
by HA antibody.
(F–H) GzmA also cleaves mouse Ndufs3 in purified
mouse complex I and inhibits complex I activity.
Complex I was purified either by immunoprecipita-
tion using a cocktail of anticomplex I subunit anti-
bodies (F) or by anion exchange and size exclusion
chromatography (G). Ndufs3 in complex I was
cleaved to a 24 kDa C-terminal fragment. Treatment
with GzmB or inactive S-AGzmA had no effect on
Ndufs3. Another complex I protein, Ndufb6, was un-
changed. (H)GzmAdisruptscomplex Iactivity.Com-
plex I activitywas assayed 15min aftermitochondria
were treated for 15 min with S-AGzmA or GzmA by
measuring NADH oxidation by absorbance at 340
nm. Inhibition of NADH oxidation required active
GzmA and increased in both a dose- and time-de-
pendentmanner (datanotshown).Means± standard
deviation (SD) are indicated. *p% 0.05 by 2-sided t
test.684 Cell 133, 681–692, May 16, 2008 ª2008 Elsevier Inc.
with the tag antibody. Neither S-AGzmA nor GzmB had any
effect on rhNDUFS3. To determine the cleavage site, both the
full-length rhNDUFS3 and the C-terminal fragment were ana-
lyzed bymass spectrometry. Tryptic peptides covering the entire
sequence were identified for the full-length protein, but the frag-
ment generated 10 peptides with residue 57 being the most
N-terminal amino acid of peptide QLSAFGEYVAEILPK, indicat-
ing cleavage after Lys56. Cleavage after a basic residue is con-
sistent with GzmA being a tryptase. Moreover, the 6.4 kDa
difference between NDUFS3 and the fragment is consistent
with removal of a 56 amino acid peptide. Therefore, GzmA likely
cleaves NDUFS3 after Lys56.
The assignment of Lys56 as the cleavage site was confirmed
by comparing GzmA cleavage of HA-tagged wild-type (WT)
NDUFS3 and a mutant variant in which Lys56 was replaced
by Ala (K56A-NDUFS3) in stably transfected K562 (Figures
3B–3D) or EL-4 cells (Figure 3E). Overexpressed NDUFS3
and K56A-NDUFS3 were incorporated into complex I since
they coimmunoprecipitated with NDUFA9, MTND6, and
NDUFB6 using an HA antibody (Figures 3B and 3C). Overex-
pression of WT or K56A-NDUFS3 did not interfere with ETC
function since cells overexpressing WT or K56A-NDUFS3 had
comparable proliferation rates, cellular ATP levels, mitochon-
drial DJm, and background ROS as cells transfected with vec-
tor (Figure S3; data not shown). When transduced K562 or EL-4
cells were treated with PFN and increasing amounts of GzmA,
K56A-NDUFS3 was relatively resistant to GzmA-mediated deg-
radation, confirming Lys56 as the GzmA cleavage site (Figures
3D and 3E). However, K56A-NDUFS3 was cleaved to some
extent. We previously found that GzmA inefficiently cleaves
two other GzmA substrates, SET and Ku70, at alternate sites
when the primary cleavage site is mutated (Zhu et al., 2006).
These findings might be explained by GzmA binding to sub-
strates by an extended exosite; if the preferred cleavage site
is unavailable, the strong interaction with residues away from
the active site may allow an alternative basic residue to be
targeted.
Recombinant human GzmA also produced a 24 kDa Ndufs3
fragment when added to purified mouse complex I, isolated by
immunocapture (Figures 3F and S2A). Cleavage was specific
since GzmB had no effect on Ndufs3. Since the method used
to purify complex I involved trichloroacetic acid (TCA) precipita-
tion, which might have altered the native conformation of
Ndufs3, we also examined GzmA cleavage of Ndufs3 in mouse
liver complex I, purified by sequential anion exchange, size
exclusion chromatography, detergent removal by dilution, and
concentration by hollow membrane cross flow filtration as de-
scribed (Sazanov et al., 2000) (Figure 3G). Only active GzmA,
but not S-AGzmA or GzmB, cleaved Ndufs3. Two other complex
I proteins, Ndufb6 and Mtnd6, were also not cleaved, again sup-
porting specificity (data not shown). Therefore, human GzmA
specifically cleaves both human and mouse NDUFS3. This is
not too surprising given the high degree of identity between
the proteins (87%). In fact, in residues 50–70 surrounding the
cleavage site, there is only a single Ala52 to Thr difference. The
similar apparent molecular masses of the mouse and human
C-terminal cleavage fragments also suggest a shared cleavage
site.GzmA Cleavage of Ndufs3 Interferes
with Complex I Activity
Complex I catalyzes the first reaction of the respiratory chain, the
oxidation of NADH to NAD+, and provides two electrons to re-
duce ubiquinone to ubiquinol (Hirst et al., 2003). To determine
whether Ndufs3 cleavage alters complex I activity, we measured
NADH oxidation by GzmA-treated purified mouse mitochondria.
GzmA, but not S-AGzmA or diisocoumarin-inactivated GzmA,
significantly inhibited NADH oxidation (Figure 3H; data not
shown). Therefore, GzmA cleavage of native Ndufs3 disrupts
complex I electron transport.
GzmA Translocates to the Mitochondrial Matrix
When PFN delivers Gzms into target cells, Gzms are first endo-
cytosed into early endosomes and then released within minutes
into the target cell cytoplasm (Keefe et al., 2005). Some Gzm
translocates to the target cell nucleus, but neither GzmA nor
GzmB is known to enter mitochondria (Chowdhury and Lieber-
man, 2008). Because NDUFS3 is a mitochondrial matrix protein,
our finding that GzmA cleaves NDUFS3 suggests that GzmA
traffics into the matrix. Immunoelectron microscopy was used
to determine whether GzmAmight be internalized intomitochon-
dria. Hsp60 staining labeled themitochondrial matrix (Figure 4A).
GzmA colocalized with Hsp60 only in cells treated with both
GzmA and PFN. These results were confirmed by quantitative
morphometry of the number of each type of gold particle per
mitochondrial surface area (Figure 4B). Moreover, GzmA and
PFN treatment severely altered mitochondrial ultrastructure as
previously noted (Figure 1B). GzmA therefore penetrates the
mitochondrial matrix to cleave NDUFS3.
GzmA Is Internalized into Isolated Mitochondria
As another test of mitochondrial import, isolated mitochondria
were incubated with Alexa 488-labeled GzmA (GzmA 488) or
with control SET 488 and then treated with trypsin to remove
any protein that had not been internalized. Mitochondria incu-
bated with GzmA 488, but not with buffer or SET 488, stained
for Alexa 488 by flow cytometry, providing additional evidence
of GzmA internalization (Figure 5A).
GzmA Binds to the Cytosolic Chaperones
Hsp70 and Hsp90
GzmAdoes not contain amitochondrial import sequence, raising
the question of how GzmA enters the mitochondrial matrix to ac-
cessNDUFS3.Moreover, GzmAdoes not disrupt theMOMsince
apoptogenic factors in the intermembrane space are not re-
leased (Martinvalet et al., 2005). Therefore, GzmA access to
the matrix is not due to indiscriminate mitochondrial disruption.
Protein trafficking into the mitochondrial matrix is highly regu-
lated. One pathway involves binding to cytosolic chaperones
Hsp70 and Hsp90 that dock onto the cytosolic portion of
Tom70, the 70 kDa subunit of the translocase of the outer mito-
chondrial membrane, as a first step in mitochondrial import
(Geissler et al., 2001; Young et al., 2003). Tom70 and Tom20
then hand off their cargo to the translocase core channel
Tom40 (Rehling et al., 2004). The 50 kDa subunit of the translo-
case of the innermitochondrial membrane Tim50 is the first com-
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intermembrane space. Although defining the pathway by which
GzmA traffics into the matrix is beyond the scope of this study,
we hypothesized that GzmA takes advantage of this pathway
for entry. In support of this idea, we previously found that
recombinant GzmA and S-AGzmA bindwith exceedingly high af-
finity to Hsp70 and Hsp27 (Beresford et al., 1998). However, Hsp
chaperones can also bind to improperly folded proteins that
might be in recombinant protein preparations. Therefore, asafirst
step to validating the interaction of GzmA with putative mito-
chondrial chaperones, we evaluated whether native GzmA binds
to Hsp70 or Hsp90. Human CTL granules were a source of native
GzmA. K562 cells were treatedwith freeze-thawed granules, and
lysates were immunoprecipitated using GzmA antibody and then
blotted for Hsp70 and Hsp90. GzmA coprecipitated with both
Hsp70 andHsp90, but not withGAPDH (Figure 5B). Furthermore,
GzmA binding to Hsp70 and Hsp90 was disrupted by amolar ex-
cess of ATP, suggesting that this interaction was specific since
Figure 4. GzmA Enters Mitochondria
(A) HeLa cells, treated with recombinant human GzmA with (right) or without
(left) PFN, were analyzed by immunoelectronmicroscopy for themitochondrial
matrix protein Hsp60 (10 nm particles, black arrows) and GzmA (15 nm, blue
arrows). Without PFN, there is no staining for GzmA. GzmA colocalizes with
Hsp60 in the matrix in cells treated with both GzmA and PFN.
(B) Morphometry quantification of the number of matrix Hsp60 (black bars) or
GzmA (white bars) gold particles per mitochondrial surface area. Means ± SD
are indicated.686 Cell 133, 681–692, May 16, 2008 ª2008 Elsevier Inc.ATP-bound Hsp70 and Hsp90 have reduced affinity for their cli-
ent proteins. In addition, recombinant human GzmA, but not re-
combinant mouse GzmB, was specifically coimmunoprecipi-
tated with both Hsp70 and Hsp90 (data not shown). The lack of
an interaction with GzmB may not be surprising since GzmB
has been reported to cleave the Hsp cofactor proteins, Hop
and Hip, as well as Hsp70 and Hsp90 (Bredemeyer et al., 2006;
Hostetter et al., 2007; Loeb et al., 2006). Nonetheless, GzmB in
the human granules did not abolish the interaction of GzmA
with Hsps. Further study will be required to determine whether
GzmB processing of Hsps and their activating cofactors affects
the GzmA mitochondrial pathway. These data suggest that al-
though GzmA does not have a mitochondrial import signal, it
may access the mitochondrial matrix by interacting with an Hsp.
Since GzmA disrupted complex I activity (Figure 3H) and was
internalized into isolatedmitochondria (Figure 5A) in the absence
of added cytosol, we wanted to know whether Hsps copurified
with themitochondrial preparation. Purifiedmousemitochondria
were either washedwith bicarbonate to remove loosely adherent
proteins or left untreated and the mitochondrial pellet was ana-
lyzed by immunoblot for Hsp proteins (Figure S4). Hsp70 and
Hsp60, but not Hsp90, were present in our mitochondrial prepa-
ration. Washing with bicarbonate partially released Hsp70, but
not the mitochondrial matrix protein Hsp60. Therefore, some
Hsp70 protein was associated with the outer membrane of the
isolated mitochondria and potentially available to chaperone
GzmA to the mitochondrial translocases.
Treating cells with the Hsp90 inhibitor 17-allylaminogeldana-
mycin (17-AAG) did not inhibit GzmA-induced ROS, cell death,
or SET cleavage and in fact enhanced each of these downstream
events (Figure S5). This suggests that Hsp90 is unlikely to be the
GzmA mitochondrial chaperone. Hsp70 may be a better candi-
date. We were unable to test an Hsp70 inhibitor because it
was too toxic to our cells. Hsp90 performs many functions in
cells and has been shown to protect mitochondria from death
stimuli in tumor cells (Kang et al., 2007), so our finding that inhib-
iting Hsp90 enhances GzmA-induced cell death may not be sur-
prising. Sorting out the roles of Hsp70 and Hsp90 in this pathway
requires further study.
GzmA Cleavage of NDUFS3 and ROS Generation
Requires DJm
Protein translocation across the mitochondrial double mem-
branes by the Tom/Tim twin translocases requires an intact
DJm (Rehling et al., 2004). To begin to test the hypothesis that
GzmA mitochondrial translocation is mediated by the Tom/Tim
system, we examined whether GzmA is able to enter mitochon-
dria and cleave Ndufs3 in purified mitochondria treated with va-
linomycin, which disrupts DJm (Daum et al., 1982). GzmA 488
entry into isolated mitochondria and cleavage of Ndufs3 were in-
hibited by preincubation with valinomycin (Figures 5A and 5C).
To assess whether valinomycin also inhibited ROS generation
in intact cells, we first verified that treatment of K562 cells with
low nanomolar concentrations of valinomycin dissipated DJm
without excessive cytotoxicity (Figure 5D; data not shown). Pre-
treatment of K562 cells with 16 nM valinomycin inhibited GzmA-
and PFN-induced ROS generation (Figure 5E). Therefore, GzmA
requires DJm to cleave Ndufs3 and induce mitochondrial
damage in cells. These data support a model in which GzmA is
carried to mitochondria by an Hsp and then internalized via the
DJm-dependent mitochondrial import machinery. However,
additional experiments are needed to test this hypothesis.
GzmA-Mediated ROS Production and Cell Death
Are Impaired in Pseudo r Cells Depleted
of Mitochondrial DNA
We next looked at the effect of transient mitochondrial DNA
(mtDNA)depletiononGzmA-inducedROSandcell death.Pseudo
r0 cells are partially depleted ofmtDNAby culture in the presence
of ethidium bromide (Kaminski et al., 2007). Because mtDNA en-
codes for genes in complex I and other key ETC proteins, these
cells rely onglycolysis toproduceATP.K562cells orK562pseudo
r0 cells, which contain about 1/5 of normal cellular mtDNA
(Figure 6A), were treatedwith PFN andGzmA to assess ROS pro-
duction and cell death. Pseudo r0 cells did not generate ROS and
were resistant to GzmA-induced cell death (Figures 6B and 6C).
These results indicate that an intact and functional ETC is needed
for GzmA-generated ROS and cell death.
Figure 5. GzmA Interacts with the Cytosolic
Chaperones Hsp70 andHsp90 andRequires
DJm to Cleave Ndufs3 and Generate ROS
(A) Fluorescently labeled GzmA (GzmA 488) is
internalized by purified mouse liver mitochondria,
but the control fluorescent recombinant SET
protein (SET 488) is not. Purified mouse liver
mitochondria were incubated with SET 488 or
GzmA 488, gently trypsinized to remove surface
proteins, and then analyzed by flow cytometry.
Valinomycin, which disrupts DJm, inhibits
GzmA entry into mitochondria. Results are repre-
sentative of at least three independent experi-
ments.
(B) GzmA interacts with Hsp70 and Hsp90, two
chaperones implicated in mitochondrial import.
K562 cells treated with buffer or freeze-thawed
human CTL granules were lysed and immuno-
precipitated (IP) using GzmA antibody in the
presence or absence of 10 mM of ATP and blotted
for Hsp70, Hsp90, GzmA, and GAPDH. GzmA
interacts with Hsp70 and Hsp90, but not
with GAPDH, but only in the absence of 10 mM
ATP, which inhibits Hsp chaperone function.
GzmA was not detected in the input, which was
loaded with 10% of the reaction mixture.
(C) Valinomycin also inhibits GzmA cleavage of
Ndufs3 in isolated mouse liver mitochondria.
(D and E) Valinomycin at nanomolar concentra-
tions that disrupt DJm (D) but are not toxic
interferes with ROS production in K562 cells
treated with GzmA and PFN (E). Cells treated
with buffer or GzmA or PFN alone are back-
ground controls.
The Complex I Inhibitor Rotenone
Hinders GzmA-Mediated ROS
Production and Cell Death
To probe further the importance of com-
plex I in GzmA-induced cell death, we
treated K562 cells, preincubated with rotenone or the superox-
ide scavenger Tiron as a positive control, with GzmA and PFN
and analyzed ROS production and cell death. As previously re-
ported (Martinvalet et al., 2005), Tiron completely inhibits ROS
production and cell death (Figures 6D and 6E). Rotenone also
inhibits both ROS generation and cell death, although not as
completely as Tiron. Pretreatment of cells with Piericidin A,
another complex I inhibitor, also blocked GzmA-mediated cell
death (data not shown).
We also investigated whether scavenging superoxide anion
with Tiron interfered with GzmA NDUFS3 cleavage. Tiron had
no effect on NDUFS3 cleavage (Figure 6F), as would be
expected if GzmA cleavage of NDUFS3 is upstream of ROS
production. However, when K562 cells were preincubated with
Tiron, SET cleavage was completely inhibited at concentrations
that scavenge all the ROS (40–80 mM) (Figure 6F). This lends ad-
ditional support to the importance of mitochondrial superoxide
production in completing the GzmA cell death program since
SET cleavage is required to activate the GzmA nucleases (Fan
et al., 2003).Cell 133, 681–692, May 16, 2008 ª2008 Elsevier Inc. 687
Expression of an NDUFS3 Cleavage Site Mutant Inhibits
GzmA-Mediated ROS Production and Cell Death
To test the importance of NDUFS3 cleavage in GzmA-mediated
cell death, we treated EL4 cells stably overexpressing WT or
K56A-NDUFS3 with GzmA and PFN. ROS production, assayed
by HE staining and flow cytometry, was reduced almost to
background in cells expressing K56A-, but not WT, NDUFS3
(Figure 7A). EL4 cells overexpressing K56A-NDUFS3 were also
more resistant to PFN- and GzmA-induced death measured by
annexin V + propidium iodide (PI) staining compared to cells ex-
pressing vector or WT NDUFS3 (Figure 7B). Overexpression of
K56A-NDUFS3 did not reduce caspase-dependent ROS gener-
ation following UV irradiation, demonstrating that this protection
was GzmA specific (Figure 7C). Cells expressing K56A-NDUFS3
were also protected from DJm dissipation (data not shown). Ex-
Figure 6. GzmA-Induced ROS Production
and Cell Death Require Complex I Activity
(A–C) Pseudo r0 K562 cells with reduced mtDNA,
assessed by quantitative PCR (A), are resistant to
GzmA-induced ROS (B) and cell death (C), as-
sayed by annexin V and PI staining. In (C), black
bars indicate K562 cells; gray bars, pseudo r0
K562 cells.
(D and E) The complex I inhibitor rotenone (Rot)
and the superoxide anion scavenger Tiron
(80 mM) inhibit GzmA-induced ROS (D) and cell
death (E). K562 cells were pretreated with rote-
none or Tiron and then incubated with PFN and/
or GzmA. Light and dark gray bars indicate cells
pretreated for 2 hr with 0.25 mM and 1 mM of rote-
none, respectively.
(F) Scavenging superoxide anion does not affect
upstream cleavage of NDUFS3 but inhibits down-
stream cleavage of SET when K562 cells are
exposed to GzmA and PFN.
For all panels, results are means ± SD for repre-
sentative experiments performed at least three
times.
pression of the NDUFS3 cleavage site
mutant in 293T and K562 cells also in-
hibited cell death by GzmA and PFN
(data not shown).
We previously showed that mitochon-
drial superoxide anion induced by GzmA
triggers the nuclear translocation of the
SET complex, which contains SET and
theGzmA-activatedDNases,NM2321-H1
andTREX1 (Martinvalet et al., 2005). Since
cells overexpressing K56A-NDUFS3
generate much less ROS when exposed
to GzmA, we investigated the effect
of K56A-NDUFS3 overexpression on
GzmA-induced SET cleavage. In both
control and WT NDUFS3-overexpressing
EL4 cells, GzmA and PFN triggered nu-
clear translocation of full-length I2PP2A
(themouseSEThomolog, data not shown)
and I2PP2A cleavage (Figure 7D). How-
ever, overexpression of K56A-NDUFS3 inhibited both I2PP2A
translocation and cleavage.
NDUFS3 Cleavage Is Critical for Cell Death
by GzmA-Expressing CTLs
We next wanted to determine whether GzmA-mediated
NDUFS3 cleavage is critical for cell death in the most relevant
model, CTL-mediated cell death. CTLs from P14 TCR trans-
genic mice kill EL4 cells coated with a lymphochoriomeningitis
virus gp33 peptide (Pircher et al., 1989). We backcrossed the
P14 Tg mice with mice genetically deficient in GzmA or
GzmB to generate gp33-specific CTL expressing only GzmB
or GzmA, respectively. We then compared the susceptibility
of gp33-coated EL4 target cells overexpressing WT or K56A-
NDUFS3 or control vector to lysis by GzmB/ P14 or688 Cell 133, 681–692, May 16, 2008 ª2008 Elsevier Inc.
GzmA/P14 CTLs by 51Cr-release assay (Figures 7E and 7F).
As expected, killing by GzmA/ CTLs was not affected by
overexpressing either WT or mutant NDUFS3 (Figure 7F). How-
ever, target cells overexpressing K56A-NDUFS3 were about
2-fold more resistant to cell death triggered by GzmB/
CTLs (Figure 7E). Overexpression of WT NDUFS3 did not
significantly protect cells from GzmB/ CTLs at any effector:
target (E:T) cell ratio (Figure 7E). However, cytolysis of K56A-
NDUFS3-transduced EL4 cells was significantly reduced at
each E:T ratio when compared to vector-transduced (p <
0.02) or WT NDUFS3-transduced cells (p < 0.03). Similar results
were observed when transduced 293T cells were substituted
for EL4 target cells (data not shown). Therefore, NDUFS3 cleav-
age plays an important role in GzmA, but not GzmB and/or cas-
pase, cell death.
Figure 7. Overexpression of a Cleavage Site
Mutant of NDUFS3 Inhibits GzmA-Induced
Mitochondrial Damage and Cell Death
Mouse EL4 cells were stably transfected with
vector, HA-tagged wild-type (WT) NDUFS3, or
K56A-NDUFS3 expression vectors (Figure 3E).
(A) EL4 cells overexpressing K56A-NDUFS3
generate reduced ROS in response to GzmA and
PFN, compared to cells transduced with WT
NDUFS3 or vector. (Adding GzmA without PFN
tended to reduce background ROS detection
in cells for all conditions for unclear reasons,
suggesting that GzmA may scavenge ROS.)
(B and C) Overexpression of K56A-NDUFS3 also
protects EL4 cells from GzmA- and PFN-induced
cell death measured by annexin V-PI staining (B)
but does not substantially affect UV-induced
ROS generation (C) or death (data not shown).
Cells were treated with buffer (), 0.5 mM GzmA
(A), PFN (P), PFN plus 0.25 mM GzmA (gray bars),
or PFN plus 0.5 mM GzmA (black bars).
(D) Mutant NDUFS3 also inhibits cleavage of the
SET homolog I2PP2A in overexpressing EL4 cells.
(E and F) These stably transfected EL4 cell lines
were coated with gp33 peptide and used as tar-
gets for CTL effector cells derived from GzmB/
(E) or GzmA/ (F) mice in a 6 hr 51Cr-release as-
say. E:T ratio, effector:target cell ratio. Black
bars represent EL4 cells transduced with vector;
white bars, WT NDUFS3; gray bars, K56A-
NDUFS3. Overexpression of K56A-NDUFS3 pro-
tects cells from GzmA-expressing GzmB/
CTLs but not from GzmA/ CTLs.
For all panels, results shown are means ± SD of at
least 4–6 independent experiments. *p % 0.02
compared with vector-transduced target cells
and p < 0.03 compared with WT NDUFS3-trans-
duced target cells.
DISCUSSION
GzmA activates a mitochondrial MOMP-
and caspase-independent death path-
way by cleaving NDUFS3 in complex I.
NDUFS3 cleavage is likely the first step
of GzmA programmed cell death. In addi-
tion to generating ROS, disruptingDJm, and interfering with ATP
generation, NDUFS3 cleavage is required for DNA damage. The
SET complex, which contains the two GzmA-activated DNases
NM23-H1 and TREX1 and their inhibitor SET, is normally extra-
nuclear (Chowdhury et al., 2006;Martinvalet et al., 2005). It trans-
locates to the nucleus in response to superoxide anion, gener-
ated by NDUFS3 cleavage. Both SET complex translocation
and SET cleavage, required to activate DNA damage, as well
as cell death, are blocked by superoxide scavengers or overex-
pression of GzmA-resistant K56A-NDUFS3.
NDUFS3 cleavage is specific since other complex I proteins
are not substrates and GzmB does not cleave NDUFS3. More-
over, NDUFS3 is a GzmA substrate in both rodents and humans.
Both mouse Ndufs3 and human NDUFS3 are cleaved by human
GzmA and both human and rat GzmA cleave mouse Ndufs3.Cell 133, 681–692, May 16, 2008 ª2008 Elsevier Inc. 689
Furthermore, GzmA disrupts complex I function. Functional
complex I is needed to generate ROS to initiate cell death since
pseudo ro cells with a deficit in ETC function are GzmA resistant.
Electron flow along the ETC is probably critical to initiate death
since electrons are needed to generate reactive free radicals.
Although ROS generation and SET complex translocation are
detected within minutes of introducing GzmA into cells, NDUFS3
cleavage is only obvious after 30 min. If NDUFS3 cleavage trig-
gers both ROS and SET complex translocation, why this appar-
ent discrepancy in kinetics? Immunoblot may be relatively insen-
sitive to protein cleavage since clearcut changes are detected
only when a significant fraction of a protein has been degraded.
However, ROS may be continuously generated every time an
NDUFS3 molecule is degraded. Native ROS scavengers may
get saturated before a large fraction of NDUFS3 molecules
have been proteolyzed.
ETC I and III are the major sources of spontaneous superoxide
anion production (Camello-Almaraz et al., 2006; Grivennikova
and Vinogradov, 2006). Complex I not only generates superoxide
radicals but also maintains the proton gradient across the inner
membrane (DJm) and is needed for ATP synthesis. Since com-
plex I is the entry point of electrons, disabling complex I disrupts
energy metabolism at its very root. Of note, caspase-3 also crip-
ples complex I by cleaving NDUFS1 (Ricci et al., 2004). More-
over, treatment with rotenone, a specific complex I inhibitor,
can by itself induce apoptosis (Li et al., 2003). Silencing NDUFS3
or another complex I subunit (GRIM-19) sensitizes some cancer
cells to cell death by IFN-b and retinoic acid (Huang et al., 2007).
A recent study also implicates complex I in activation-induced T
cell death (Kaminski et al., 2007). Both HIV-1 and cytomegalovi-
rus have devised strategies to interfere with complex I expres-
sion or mitochondrial localization (Ladha et al., 2005; Reeves
et al., 2007). Since complex I is the first step in energy metabo-
lism and redox pathways, it is not surprising that multiple cell
death pathways have disabled it. Our results suggest that oxy-
gen radicals produced by disrupting complex I in these various
pathways are not mere byproducts of cell death but are central
to its execution.
Superoxide scavengers also block cell death by GzmB-
expressing CTLs (Malassagne et al., 2001; Martinvalet et al.,
2005). GzmB induces MOMP by cleaving bid and activating cas-
pase-3 but can also activate caspase-independent mitochon-
drial damage (Heibein et al., 1999). In fact, GzmB cell death is
unimpaired in cells lacking both bax and bad, mediators of
bid-induced MOMP, or by caspase inhibition (Heibein et al.,
1999; MacDonald et al., 1999; Thomas et al., 2001; Wang
et al., 2001). Preliminary data suggest that GzmB might also
directly target complex I. Another Gzm, mouse GzmC (most
homologous to human GzmH), dramatically alters mitochondrial
morphology without cleaving bid or activating the caspases
(Johnson et al., 2003). Therefore, mitochondrial disruption may
be central to all Gzm death pathways.
A proteomics approachwould be a good starting point to iden-
tify mitochondrial substrates of other Gzm. The manageable
number of mitochondrial proteins, compared to the whole cell
proteome, and using intact mitochondria, rather than mitochon-
drial lysates, likely enhanced our ability to identify a relevant sub-
strate. Reducing the incubation time and granzyme concentra-690 Cell 133, 681–692, May 16, 2008 ª2008 Elsevier Inc.tion also favored identifying relevant substrates. Our 2D gels
demonstrate the lack of indiscriminate proteolysis by GzmA.
NDUFS3 now joins a small list of validated GzmA substrates.
We were surprised to find that GzmA cleaves a mitochondrial
matrix protein. Complex I is embedded in themitochondrial inner
membrane with a stalk that sticks into the matrix. The exact
structure of mammalian complex I is unknown, although its
structure has been inferred from subcomplexes that remain
intact after exposure to detergents, by subassemblies formed
in cells carrying mutations of different subunits, from low-resolu-
tion structures of the bovine complex, and from the crystal struc-
ture of the bacterial complex I (NDH-1) resolved at 3.3 A˚ (Saza-
nov et al., 2000). NDH-1 has 14 subunits, which all have
mammalian orthologs and constitute the core of complex I.
NDUFS3 is a core component, the ortholog of bacterial Nqo5.
Nqo5 is well exposed in the connecting stalk that links the
peripheral arm to the membrane arm of the complex. Although
the mammalian enzyme has additional subunits, NDUFS3 likely
occupies a similar position in the stalk. Furthermore, the con-
necting stalk is the narrowest segment of bovine complex I
and therefore is unlikely to house additional peptides. GzmA
cleavage of NDUFS3 supports the leading current model of com-
plex I topology in which both NDUFS3 and the caspase sub-
strate NDUFS1 are accessible in the matrix-protruding stalk
(Hirst et al., 2003; Ricci et al., 2004). However, both GzmA and
caspase-3 need to access the matrix to cleave their complex I
targets. Even if MOMP allows caspase-3 into the intermembrane
space, caspase-3 would still need to transit across the inner
mitochondrial membrane to cleave NDUFS1.
GzmA lacks a mitochondrial import signal but nonetheless
traffics to the mitochondrial matrix without causing MOMP. Dis-
rupting DJm before adding GzmA inhibits NDUFS3 cleavage
and ROS generation. Therefore, DJm is required for GzmA to
enter the matrix, and thus DJm dissipation occurs after GzmA
has gotten into mitochondria. The DJm-dependent twin-pore
translocase might be involved in GzmA mitochondrial import.
Imported cargo is brought to the outer membrane translocase
by Hsps (Geissler et al., 2001; Young et al., 2003). Hsp27 and
Hsp70 bind to immobilized recombinant S-AGzmA so tightly
that 6 M urea is needed to disrupt binding (Beresford et al.,
1998). Nowwe have verified this Hsp-GzmA interaction by show-
ing that Hsp70 and Hsp90 coprecipitate in an ATP-dependent
manner with native GzmA.
EXPERIMENTAL PROCEDURES
Gzm and PFN Treatment
Cells were washed in HBSS and 53 104 cells were resuspended in 60 ml load-
ing buffer (HBSS with 10 mM HEPES, pH 7.2, 0.4% BSA, 3 mM CaCl2). A sub-
lytic concentration of PFN (the concentration that lyses 5%–15% of cells) and/
or GzmA orGzmB (1 mMor as indicated) was added and the cells were cultured
at 37C for the indicated time. When inhibitors were used, cells were preincu-
bated for up to 2 hr with the inhibitor before adding GzmA and PFN for 1 hr.
NP40 cell lysates obtained after 1 hr incubation were analyzed by immunoblot.
For cell death assays, cells were stainedwith annexin V and PI 1 hr after adding
PFN and/or Gzm and analyzed by flow cytometry (Martinvalet et al., 2005).
Dead cells were defined as the sum of all annexin V+ and/or PI+ cells. For elec-
tron microscopy, 106 HeLa cells in aliquots of 23 104 /60 ml were treated with
GzmA and/or PFN for 10 min and washed in HBSS before fixation in 4%
paraformaldehyde for 2 hr.
ROS Production and DJm
ROS production was monitored by adding 2 mMHE just before flow cytometry
analysis. Changes in DJm were monitored with the potentiometric dye JC-1
using the Mitochondrial Membrane Potential Detection Kit (BioCarta, San
Diego, CA, USA). Control cells were cultured overnight after UV irradiation
(200 mJ/cm2 3 5 min). Flow cytometry was performed using a Becton Dickin-
son FACSCalibur flow cytometer and Cellquest Pro software.
Isolated Mitochondria Assays
Mitochondria and S100 supernatants were freshly prepared from mouse liver
as described (Susin et al., 2000). Mitochondria (0.5 mg/ml protein) were incu-
bated with or without S100 supernatant (1 mg/ml) plus Gzms at indicated con-
centrations in 60 ml of mitochondrial buffer (220 mM sucrose, 68 mMmannitol,
10 mM KCl, 5 mM KH2PO4, 2 mM MgCl2, 0.5 mM EGTA, 5 mM succinate,
2 mM rotenone, 10 mM HEPES, pH 7.2) for 30 min at 37C. Mitochondria
were stained with 150 mM HE for flow cytometry as above. To determine
whether Hsps were contained in mitochondrial preparations, mitochondria
were washed at 4C with 0.2 M HCO3 (pH 10) or mitochondrial buffer.
Mitochondrial import was assessed as reported (Young et al., 2003) with
slight modification. Purified mouse mitochondria were preincubated at room
temperature for 20 min with or without valinomycin before adding 1 mM
SET-Alexa 488 or 2 mM GzmA-Alexa 488 for 20 min at room temperature
(RT). Treated mitochondria were washed in the same buffer and then incu-
bated with 2.5 mg/ml trypsin for 10 min at 4C. The reaction was stopped
with 1 mM PMSF. After further washing, fluorescence was evaluated.
Live-Cell Imaging for ROS Production
HeLa cells (53 104 cells/well), plated overnight on collagen-coated coverslips
(VWR) in 6-well plates, were stained for 1 hr at 37C with 25 nM MitoTracker
Deep Red plus 2.5 mM MitoSOX Red in DMEM complete medium. After three
washes, cells were incubated in complete medium for 30 min at 37C. Just
before imaging, cover slides were washed three times in warm HBSS and in-
cubated in a heated imaging chamber containing 1 ml loading buffer with PFN
and/or 0.4 mMGzmA. Fluorescence was observed immediately with a Zeiss la-
ser-scanning fluorescent microscope and SlideBook 4.0 OS3 digital imaging
software.
Complex I Purification and Activity
Complex I was purified as reported by Carroll et al. (2003) and Sazanov et al.
(2000). Complex I activity was monitored by measuring the conversion of
NADH into NAD+, as reported (Yamaguchi et al., 1998).
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